Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

FLGT

Fulgent Genetics Inc

Dec 13 • 04:00PM ET

19.58

Dollar change -0.66
Percentage change -3.26	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN QGEN EXAS GH CDNA TXG BGNE VCYT MYGN OMIC

| Held by: IJR VTI IWM VXF IJS IWN SPSM DFAT IBB SLYV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-5.53	Insider Own	34.54%	Shs Outstand	30.54M	Perf Week	-2.54%
Market Cap	579.36M	Forward P/E	-	EPS next Y	-0.15	Insider Trans	-0.14%	Shs Float	20.02M	Perf Month	6.30%
Income	-164.97M	PEG	-	EPS next Q	-0.12	Inst Own	53.12%	Short Float	3.74%	Perf Quarter	-11.40%
Sales	277.76M	P/S	2.09	EPS this Y	179.37%	Inst Trans	5.67%	Short Ratio	3.62	Perf Half Y	2.57%
Book/sh	37.28	P/B	0.53	EPS next Y	-147.31%	ROA	-12.73%	Short Interest	0.75M	Perf Year	-31.51%
Cash/sh	7.20	P/C	2.72	EPS next 5Y	-	ROE	-13.76%	52W Range	16.56 - 30.68	Perf YTD	-32.27%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-78.39%	ROI	-14.39%	52W High	-36.18%	Beta	1.41
Dividend TTM	-	Quick Ratio	4.41	Sales past 5Y	258.65%	Gross Margin	33.36%	52W Low	18.24%	ATR (14)	0.93
Dividend Ex-Date	-	Current Ratio	4.41	EPS Y/Y TTM	-158.64%	Oper. Margin	-31.92%	RSI (14)	50.56	Volatility	4.52% 4.78%
Employees	1184	Debt/Eq	0.01	Sales Y/Y TTM	-3.02%	Profit Margin	-59.39%	Recom	2.67	Target Price	26.33
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	-10.28%	Payout	-	Rel Volume	1.06	Prev Close	20.24
Sales Surprise	0.03%	EPS Surprise	301.56%	Sales Q/Q	-15.28%	Earnings	Nov 08 BMO	Avg Volume	206.88K	Price	19.58
SMA20	4.16%	SMA50	-0.18%	SMA200	-7.62%	Trades		Volume	219,539	Change	-3.26%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-07-23	Initiated	UBS	Neutral	$35
Dec-08-22	Downgrade	Piper Sandler	Overweight → Neutral	$65 → $40
Nov-18-22	Initiated	Raymond James	Outperform	$45
Aug-25-22	Initiated	Credit Suisse	Outperform	$65
Feb-04-22	Resumed	Piper Sandler	Overweight	$80
Aug-05-21	Resumed	Credit Suisse	Underperform	$55
Jan-08-21	Downgrade	Credit Suisse	Neutral → Underperform	$42 → $40
Nov-24-20	Downgrade	BTIG Research	Buy → Neutral
Aug-20-20	Initiated	Oppenheimer	Outperform	$75
May-29-20	Initiated	BTIG Research	Buy	$20
Nov-05-19	Upgrade	Piper Jaffray	Neutral → Overweight
Mar-01-18	Downgrade	Piper Jaffray	Overweight → Neutral
Nov-07-17	Downgrade	Raymond James	Outperform → Mkt Perform

Show Previous Ratings

Dec-09-24 09:55AM	Wall Street Analysts Predict a 31.06% Upside in Fulgent Genetics (FLGT): Here's What You Should Know (Zacks)
Nov-22-24 12:00PM	All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy (Zacks) +5.43%
Nov-19-24 07:16PM	Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey)
Nov-09-24 07:31AM	Fulgent Genetics Reports Strong Q3 2024 Results (TipRanks)
02:05AM	Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline (GuruFocus.com)
08:15AM	Loading…
Nov-08-24 08:15AM	Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates (Zacks) -11.76%
07:00AM	Fulgent Reports Third Quarter 2024 Financial Results (Business Wire)
Nov-05-24 08:00AM	Fulgent to Participate in Upcoming Conferences (Business Wire)
Nov-01-24 08:08AM	Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains? (Zacks)
Oct-31-24 08:00AM	Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1 (Business Wire) +5.82%
Oct-17-24 04:05PM	Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024 (Business Wire)
Aug-13-24 12:00PM	Fulgent Genetics (FLGT) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
09:55AM	How Much Upside is Left in Fulgent Genetics (FLGT)? Wall Street Analysts Think 27.22% (Zacks)
Aug-02-24 08:15AM	Fulgent Genetics, Inc. (FLGT) Beats Q2 Earnings and Revenue Estimates (Zacks) +6.32%
07:00AM	Fulgent Reports Second Quarter 2024 Financial Results (Business Wire)
04:36AM	Loading…
Jul-18-24 04:36AM	Fulgent Genetics (FLGT) Soars 6.6%: Is Further Upside Left in the Stock? (Zacks) -5.53%
Jul-11-24 04:05PM	Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024 (Business Wire) +5.41%
Jun-10-24 01:00AM	Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing (GlobeNewswire)
Jun-03-24 08:00AM	Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer (Business Wire)
May-24-24 08:00AM	Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting (Business Wire)
May-15-24 04:21AM	Moffitt and Fulgent Pharma partner on personalised cancer therapies (Pharmaceutical Technology)
May-14-24 04:05PM	Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics (Business Wire)
09:00AM	Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain (PR Newswire)
May-04-24 09:15AM	Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:04AM	Fulgent Genetics Inc (FLGT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
May-03-24 10:46PM	Q1 2024 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents)
11:53AM	FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
08:34AM	Fulgent Genetics Inc (FLGT) Q1 2024 Earnings: Misses Analyst Forecasts with Wider Losses (GuruFocus.com)
08:15AM	Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Fulgent Reports First Quarter 2024 Financial Results (Business Wire)
04:05PM	Loading…
Apr-11-24 04:05PM	Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024 (Business Wire)
Feb-29-24 09:31AM	Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 10:18PM	Q4 2023 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents) -8.14%
07:35AM	Fulgent Genetics Inc (FLGT) Faces GAAP Loss Despite Core Revenue Growth in 2023 (GuruFocus.com)
07:00AM	Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-13-24 08:00AM	Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024 (Business Wire)
Feb-09-24 08:31AM	Cord Blood Registry (CBR) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing (PR Newswire)
Nov-25-23 09:45AM	The 3 Best Digital Health Stocks for Personalized Medicine (InvestorPlace)
Nov-14-23 04:30PM	Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference (Business Wire)
Nov-05-23 09:02AM	Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-03-23 10:26PM	Q3 2023 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents) +13.24%
04:05PM	Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting (Business Wire)
08:52AM	Fulgent Genetics Inc (FLGT) Reports Q3 2023 Financial Results (GuruFocus.com)
08:45AM	Fulgent Genetics, Inc. (FLGT) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Fulgent Reports Third Quarter 2023 Financial Results (Business Wire)
Oct-30-23 03:46PM	Top 20 Genomics Companies in the World (Insider Monkey)
Oct-25-23 08:00AM	Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting (Business Wire)
Oct-18-23 09:44AM	Strength Seen in Olink Holding AB (publ) Sponsored ADR (OLK): Can Its 66.0% Jump Turn into More Strength? (Zacks)
Oct-17-23 08:00AM	Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023 (Business Wire)
Aug-05-23 08:56AM	Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-04-23 10:08PM	Q2 2023 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents) -12.82%
08:15AM	Fulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Fulgent Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-24-23 04:05PM	Exagen Inc. Appoints Paul Kim to Board of Directors (GlobeNewswire)
Jul-18-23 08:00AM	Fulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023 (Business Wire)
Jun-21-23 08:00PM	FLGT: Lowering target price to $29.00 (Argus Research)
Jun-14-23 11:40AM	10 DNA Stocks Billionaires Are Loading Up On (Insider Monkey)
Jun-06-23 07:45AM	Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist (Motley Fool)
Jun-05-23 08:30AM	Fulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various Cancers (Business Wire)
May-23-23 09:53AM	Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics (Motley Fool)
08:20AM	2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years (Motley Fool)
May-18-23 04:05PM	Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2023 Annual Meeting (Business Wire) +6.13%
May-08-23 11:15AM	3 Cash-Rich Biotechs in a Market That's Tough on the Debt Burdened (TheStreet.com)
09:40AM	Is Fulgent Genetics (FLGT) Stock Outpacing Its Medical Peers This Year? (Zacks)
May-05-23 08:15AM	Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +18.97%
07:00AM	Fulgent Reports First Quarter 2023 Financial Results (Business Wire)
Apr-26-23 08:00PM	FLGT: Rating increased to a HOLD (Argus Research)
Apr-20-23 04:05PM	Fulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023 (Business Wire)
Apr-16-23 02:01PM	7 Stocks to Buy to Bag Big-Time Returns in Q2 (InvestorPlace)
Apr-14-23 07:13AM	Returns Are Gaining Momentum At Fulgent Genetics (NASDAQ:FLGT) (Simply Wall St.)
06:49AM	Strength Seen in Nyxoah SA (NYXH): Can Its 10.2% Jump Turn into More Strength? (Zacks)
Apr-12-23 09:40AM	Are Medical Stocks Lagging Fulgent Genetics (FLGT) This Year? (Zacks)
Apr-11-23 08:00AM	Mission Bio Partners with Fulgent Genetics to Broaden Accessibility of Single-Cell Multi-Omics for Drug Development and Clinical Research (PR Newswire)
Mar-27-23 09:40AM	Is Fulgent Genetics (FLGT) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-24-23 03:54PM	Fulgent Genetics (NASDAQ:FLGT) shareholders are still up 654% over 5 years despite pulling back 7.1% in the past week (Simply Wall St.)
Mar-09-23 09:40AM	Is Fulgent Genetics (FLGT) Outperforming Other Medical Stocks This Year? (Zacks)
Mar-04-23 07:50AM	Earnings Beat: Fulgent Genetics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models (Simply Wall St.)
Mar-03-23 11:17AM	Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-01-23 10:13AM	Q4 2022 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-23 08:25PM	Fulgent Genetics, Inc. (FLGT) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results (Business Wire)
04:03PM	Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel (Business Wire)
Feb-26-23 09:05AM	This Medical Play Is Up to the Test (TheStreet.com)
Feb-23-23 04:05PM	Fulgent to Participate in the Raymond James & Associates 44th Annual Institutional Investors Conference (Business Wire)
Feb-14-23 04:05PM	Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023 (Business Wire)
Feb-03-23 05:18AM	Is Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Latest Stock Performance A Reflection Of Its Financial Health? (Simply Wall St.)
Jan-03-23 04:05PM	Fulgent Expands Board of Directors with Addition of Reggie Groves (Business Wire)
Dec-15-22 08:11AM	My Top 7 Strong Conviction Buys for 2023 (InvestorPlace)
Dec-02-22 12:08PM	Owning 45% shares,institutional owners seem interested in Fulgent Genetics, Inc. (NASDAQ:FLGT), (Simply Wall St.)
Nov-24-22 10:30AM	1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings (Motley Fool)
Nov-17-22 04:05PM	Fulgent Genetics to Participate in Piper Sandlers 34th Annual Healthcare Conference (Business Wire)
Nov-16-22 06:52AM	What Does The Future Hold For Fulgent Genetics, Inc. (NASDAQ:FLGT)? These Analysts Have Been Cutting Their Estimates (Simply Wall St.)
Nov-09-22 08:02AM	Fulgent Genetics Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-07-22 05:55PM	Fulgent Genetics, Inc. (FLGT) Beats Q3 Earnings and Revenue Estimates (Zacks) -6.48%
04:06PM	Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company (Business Wire)
04:05PM	Fulgent Genetics Reports Third Quarter 2022 Financial Results (Business Wire)
Oct-26-22 07:54AM	Fulgent Genetics (NASDAQ:FLGT) Is Investing Its Capital With Increasing Efficiency (Simply Wall St.)
Oct-25-22 04:03PM	Fulgent Genetics to Participate in Credit Suisses 31st Annual Healthcare Conference (Business Wire)
Oct-20-22 04:03PM	Fulgent Genetics to Announce Third Quarter 2022 Financial Results on Monday November 7, 2022 (Business Wire)
Oct-10-22 11:31AM	Those who invested in Fulgent Genetics (NASDAQ:FLGT) five years ago are up 833% (Simply Wall St.)

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Xie Jian	President and COO	Dec 03 '24	Sale	19.50	1,455	28,372	334,681	Dec 04 04:41 PM
Gao Hanlin	Chief Scientific Officer	Dec 03 '24	Sale	19.50	1,373	26,773	919,469	Dec 04 04:40 PM
Gao Hanlin	Officer	Dec 02 '24	Proposed Sale	19.25	1,397	26,892		Dec 02 07:10 PM
Xie Jian	Officer	Dec 02 '24	Proposed Sale	19.25	1,483	28,548		Dec 02 07:10 PM
Hsieh Ming	Chief Executive Officer	Nov 25 '24	Sale	18.26	2,227	40,663	703,711	Nov 27 05:00 PM
Gao Hanlin	Chief Scientific Officer	Nov 25 '24	Sale	18.26	497	9,075	920,842	Nov 27 05:00 PM
Xie Jian	President and COO	Nov 25 '24	Sale	18.26	689	12,581	336,136	Nov 27 05:00 PM
Xie Jian	Officer	Nov 25 '24	Proposed Sale	18.26	689	12,581		Nov 25 07:04 PM
Gao Hanlin	Officer	Nov 25 '24	Proposed Sale	18.26	497	9,075		Nov 25 07:03 PM
Hsieh Ming	Owner	Nov 25 '24	Proposed Sale	18.26	2,227	40,663		Nov 25 07:03 PM
Kim Paul	CFO and Treasurer	Sep 03 '24	Sale	21.96	1,674	36,763	209,481	Sep 05 04:21 PM
Xie Jian	President and COO	Sep 03 '24	Sale	21.96	1,594	35,006	341,170	Sep 05 04:21 PM
Gao Hanlin	Chief Scientific Officer	Sep 03 '24	Sale	21.96	1,503	33,007	923,057	Sep 05 04:20 PM
Xie Jian	Officer	Sep 03 '24	Proposed Sale	21.96	1,594	35,006		Sep 03 07:37 PM
Kim Paul	Officer	Sep 03 '24	Proposed Sale	21.96	1,674	36,763		Sep 03 07:36 PM
Gao Hanlin	Chief Scientific Officer	Aug 27 '24	Sale	22.83	563	12,855	924,560	Aug 29 06:34 PM
Xie Jian	President and COO	Aug 27 '24	Sale	22.83	715	16,326	342,764	Aug 29 06:33 PM
Hsieh Ming	Chief Executive Officer	Aug 27 '24	Sale	22.83	2,313	52,813	707,275	Aug 29 06:33 PM
Kim Paul	CFO and Treasurer	Aug 27 '24	Sale	22.83	733	16,737	211,155	Aug 29 06:33 PM
Hsieh Ming	Owner	Aug 27 '24	Proposed Sale	22.83	2,313	52,813		Aug 27 08:22 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

FLGT

Fulgent Genetics Inc

Upgrade your FINVIZ experience